Walker P, Weichsel M E, Hoath S B, Poland R E, Fisher D A
Endocrinology. 1981 Aug;109(2):582-7. doi: 10.1210/endo-109-2-582.
Testosterone propionate (TP) and corticosterone acetate (CA) were administered alone and in combination with T4 to assess the effect on submaxillary gland (SMG) nerve growth factor (NGF) and epidermal growth factor (EGF) concentrations in adult female mice. Mice were treated for 5 or 10 days. SMG NGF, and EGF concentrations were measured by specific RIA techniques. Mean SMG NGF (0.68 +/- 0.08 microgram/mg protein) and EGF (0.58 +/- 0.05 microgram/mg protein) concentrations were similar in control mice. T4 (0.4 microgram/g BW, sc, daily) significantly increased mean SMG NGF and EGF concentrations to 469% and 347%, respectively, of control values after 5 days and to 1190% and 568%, respectively, after 10 days of treatment. TP (25 microgram/g BW, sc, every 2 days) significantly increased mean SMG NGF and EGF concentrations to 734% and 767%, respectively, of control values at 5 days and to 1971% and 1953%, respectively, at 10 days. T4 and TP resulted in no further significant increases in either SMG NGF or EGF concentrations above the levels observed after TP alone. CA (25 microgram/g BW, sc, daily) increased mean SMG NGF, but not EGF, concentrations at both 5 and 10 days. Moreover, T4 and CA appeared to exert an additive effect on NGF. In contrast to the observations in adult female mice, T4 increased mean SMG NGF concentrations to 178% of control levels in adult male mice, but had no significant effect of SMG EGF concentrations. These data indicate that T4 and TP modulate SMG NGF and EGF concentrations in adult female mice. T4, however, appears to have a preferential effect on NGF on both male and female mice, unlike the equal effect on TP on both NGF and EGF. CA, like T4, also appears to increase NGF, but not EGF, concentrations in adult female SMG. The present results suggest separate regulatory mechanisms for T4, TP, and CA on SMG NGF and EGF biosyntheses.
单独给予丙酸睾酮(TP)和醋酸皮质酮(CA),并将它们与甲状腺素(T4)联合使用,以评估其对成年雌性小鼠颌下腺(SMG)神经生长因子(NGF)和表皮生长因子(EGF)浓度的影响。对小鼠进行5天或10天的治疗。通过特定的放射免疫分析(RIA)技术测量SMG的NGF和EGF浓度。对照小鼠的平均SMG NGF浓度(0.68±0.08微克/毫克蛋白)和EGF浓度(0.58±0.05微克/毫克蛋白)相似。T4(0.4微克/克体重,皮下注射,每日)在治疗5天后显著增加平均SMG NGF和EGF浓度,分别达到对照值的469%和347%,在治疗10天后分别达到1190%和568%。TP(25微克/克体重,皮下注射,每2天一次)在5天时显著增加平均SMG NGF和EGF浓度,分别达到对照值的734%和767%,在10天时分别达到1971%和1953%。T4和TP导致SMG NGF或EGF浓度没有比单独使用TP后观察到的水平进一步显著增加。CA(25微克/克体重,皮下注射,每日)在5天和10天时均增加平均SMG NGF浓度,但不增加EGF浓度。此外,T4和CA似乎对NGF有相加作用。与成年雌性小鼠的观察结果相反,T4使成年雄性小鼠的平均SMG NGF浓度增加到对照水平的178%,但对SMG EGF浓度没有显著影响。这些数据表明,T4和TP调节成年雌性小鼠SMG的NGF和EGF浓度。然而,T4似乎对雄性和雌性小鼠的NGF都有优先作用,这与TP对NGF和EGF的同等作用不同。CA与T4一样,似乎也会增加成年雌性SMG中的NGF浓度,但不会增加EGF浓度。目前的结果表明,T4、TP和CA对SMG NGF和EGF生物合成有不同的调节机制。